Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms

Molecular Endocrinology

Volumn 23, Issue 6, 2009, Pages 809-826

  Quiles, Ignacio ^a   Millán Ariño, Lluís ^a   Subtil Rodríguez, Alicia ^a   Miñana, Belén ^a   Spinedi, Nora ^a   Ballaré, Cecilia ^a   Beato, Miguel ^a   Jordan, Albert ^a,b  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GESTAGEN; HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE RECEPTOR; ZINC FINGER PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL LINE; CELL PROLIFERATION; DIMERIZATION; DNA BINDING; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MUTANT; MUTATIONAL ANALYSIS; ONCOGENE SRC; PRIORITY JOURNAL; TRANSACTIVATION;

EID: 66449134562     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0454     Document Type: Article

References (45)

1. Beato M, Herrlich P, Schütz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857 (Pubitemid 26006527)
2. Edwards DP 2005 Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 67:335-376 (Pubitemid 40409510)
3. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300 (Pubitemid 26093465)
4. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F 2001 PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20:6050-6059 (Pubitemid 33049280)
5. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP 2001 Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8:269-280 (Pubitemid 32831545)
6. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchio F 1998 Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17:2008-2018 (Pubitemid 28154530)
7. Ballaré C, Uhrig M, Bechtold T, Sancho E, Di Domenico M, Migliaccio A, Auricchio F, Beato M 2003 Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol Cell Biol 23:1994-2008 (Pubitemid 36278811)
8. Ballaré C, Vallejo G, Vicent GP, Saragüeta P, Beato M 2006 Progesterone signaling in breast and endometrium. J Steroid Biochem Mol Biol 102:2-10 (Pubitemid 44750650)
9. Saitoh M, Ohmichi M, Takahashi K, Kawagoe J, Ohta T, Doshida M, Takahashi T, Igarashi H, Mori-Abe A, Du B, Tsutsumi S, Kurachi H 2005 Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-κB cascade in human breast cancer cells. Endocrinology 146:4917-4925 (Pubitemid 41446630)
10. Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt AR, Molinolo AA, Frahm I, Charreau EH, Schillaci R, Elizalde PV 2005 Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol Cell Biol 25:4826-4840 (Pubitemid 40781085)
11. Lange CA, Richer JK, Horwitz KB 1999 Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13:829-836 (Pubitemid 30645301)
12. Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB 1997 Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11:1593-1607 (Pubitemid 27435408)
13. Vicent GP, Ballaré C, Nacht AS, Clausell J, Subtil- Rodríguez A, Quiles I, Jordan A, Beato M 2006 Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol Cell 24:367-381 (Pubitemid 44649285)
14. Subtil-Rodríguez A, Millán-Ariño L, Quiles I, Ballaré C, Beato M, Jordan A 2008 Progesterone induction of the 11β-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking. Mol Cell Biol 28:3830-3849
15. Jacobsen BM, Schittone SA, Richer JK, Horwitz KB 2005 Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptorpositive breast cancer: PR isoform-specific gene regulation and tumor biology. Mol Endocrinol 19:574-587 (Pubitemid 40349432)
16. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB 2002 Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209-5218 (Pubitemid 34968565)
17. Huse B, Verca SB, Matthey P, Rusconi S 1998 Definition of a negative modulation domain in the human progesterone receptor. Mol Endocrinol 12:1334-1342 (Pubitemid 128496195)
18. Sartorius CA, Shen T, Horwitz KB 2003 Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts. Breast Cancer Res Treat 79:287-299 (Pubitemid 36750936)
19. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL 1995 Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 55:5063-5068
20. Gong W, Chávez S, Beato M 1997 Point mutation in the ligand-binding domain of the progesterone receptor generates a transdominant negative phenotype. Mol Endocrinol 11:1476-1485 (Pubitemid 27366758)
21. Takimoto GS, Tasset DM, Eppert AC, Horwitz KB 1992 Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc Natl Acad Sci USA 89:3050-3054
22. Barrero MJ, Malik S 2006 Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation. Mol Cell 24:233-243 (Pubitemid 44557129)
23. Kaspar F, Klocker H, Denninger A, Cato AC 1993 A mutant androgen receptor from patients with Reifenstein syndrome: identification of the function of a conserved alanine residue in the D box of steroid receptors. Mol Cell Biol 13:7850-7858 (Pubitemid 23354309)
24. Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB 1994 New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868-3877 (Pubitemid 24241209)
25. Jacobsen BM, Richer JK, Schittone SA, Horwitz KB 2002 New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. J Biol Chem 277:27793-27800 (Pubitemid 34966724)
26. Vicent GP, Nacht AS, Smith CL, Peterson CL, Dimitrov S, Beato M 2004 DNA instructed displacement of histones H2A and H2B at an inducible promoter. Mol Cell 16:439-452 (Pubitemid 39504797)
27. Aoyagi S, Archer TK 2008 Nicotinamide uncouples hormone-dependent chromatin remodeling from transcription complex assembly. Mol Cell Biol 28:30-39
28. Faivre EJ, Daniel AR, Hillard CJ, Lange CA 2008 Progesterone receptor rapid signaling mediates Ser345 phosphorylation and tethering to Sp1 transcription factors. Mol Endocrinol 22:823-837
29. Owen GI, Richer JK, Tung L, Takimoto G, Horwitz KB 1998 Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273:10696-10701 (Pubitemid 28227684)
30. Castoria G, Barone MV, Di Domenico M, Bilancio A, Ametrano D, Migliaccio A, Auricchio F 1999 Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J 18:2500-2510 (Pubitemid 29213282)
31. Cicatiello L, Addeo R, Sasso A, Altucci L, Petrizzi VB, Borgo R, Cancemi M, Caporali S, Caristi S, Scafoglio C, Teti D, Bresciani F, Perillo B, Weisz A 2004 Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol Cell Biol 24:7260-7274 (Pubitemid 39014451)
32. Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M 2006 A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 20:2513-2526 (Pubitemid 44396837)
33. Qiu M, Olsen A, Faivre E, Horwitz KB, Lange CA 2003 Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Mol Endocrinol 17:628-642 (Pubitemid 36403575)
34. Lange CA, Shen T, Horwitz KB 2000 Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97:1032-1037 (Pubitemid 30080807)
35. Skildum A, Faivre E, Lange CA 2005 Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol Endocrinol 19:327-339 (Pubitemid 40223458)
36. Kucera T, Waltner-Law M, Scott DK, Prasad R, Granner DK 2002 A point mutation of the AF2 transactivation domain of the glucocorticoid receptor disrupts its interaction with steroid receptor coactivator 1. J Biol Chem 277:26098-26102 (Pubitemid 34967093)
37. Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, O'Malley BW 1998 The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem 273:12101-12108 (Pubitemid 28240570)
38. Tung L, Abdel-Hafiz H, Shen T, Harvell DM, Nitao LK, Richer JK, Sartorius CA, Takimoto GS, Horwitz KB 2006 Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B. Mol Endocrinol 20:2656-2670 (Pubitemid 44833528)
39. Thomson S, Mahadevan LC, Clayton AL 1999 MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Semin Cell Dev Biol 10:205-214 (Pubitemid 129502412)
40. Grillo M, Bott MJ, Khandke N, McGinnis JP, Miranda M, Meyyappan M, Rosfjord EC, Rabindran SK 2006 Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Breast Cancer Res Treat 95:185-194
41. Arnold A, Papanikolaou A 2005 Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 23:4215-4224 (Pubitemid 46211327)
42. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP 2007 The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol 21:359-375 (Pubitemid 46184890)
43. Truss M, Bartsch J, Schelbert A, Haché RJ, Beato M 1995 Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J 14:1737-1751
44. Knuesel M, Wan Y, Xiao Z, Holinger E, Lowe N, Wang W, Liu X 2003 Identification of novel protein-protein interactions using a versatile mammalian tandem affinity purification expression system. Mol Cell Proteomics 2:1225-1233
45. Strutt H, Paro R 1999 Mapping DNA target sites of chromatin proteins in vivo by formaldehyde crosslinking. Methods Mol Biol 119:455-467